Nanoviricides (AMEX:NNVC) reported quarterly earnings results on February 17, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.11, missing the consensus estimate of $-0.10 by $0.01 per share. Revenue came in at , meeting the estimate of .
Nanoviricides's stock moved following the earnings release. The stock currently trades at $0.98 with a market capitalization of $23.1M.